Stryker (NYSE:SYK) Given New $409.00 Price Target at Truist Financial
Stryker (NYSE:SYK – Free Report) had its target price upped by Truist Financial from $380.00 to $409.00 in a research report report published on Wednesday morning,Benzinga reports. The firm currently has a hold rating on the medical technology company’s stock. A number of other research analysts have also recently weighed in on the company. UBS […]
More Stories
Halozyme Therapeutics (NASDAQ:HALO) Receives “Buy” Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on...
Wedbush Forecasts PepGen’s FY2028 Earnings (NASDAQ:PEPG)
PepGen Inc. (NASDAQ:PEPG – Free Report) – Equities research analysts at Wedbush raised their FY2028 earnings per share (EPS) estimates...
What is Zacks Research’s Estimate for SYF FY2026 Earnings?
Synchrony Financial (NYSE:SYF – Free Report) – Equities research analysts at Zacks Research upped their FY2026 earnings per share (EPS)...
Enterprise Products Partners (NYSE:EPD) Lowered to “Equal Weight” Rating by Wells Fargo & Company
Wells Fargo & Company lowered shares of Enterprise Products Partners (NYSE:EPD – Free Report) from an overweight rating to an...
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low – What’s Next?
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report)’s share price reached a new 52-week low during trading on Thursday ....
Direxion Daily Regional Banks Bull 3x Shares (NYSEARCA:DPST) Shares Gap Up – Still a Buy?
Direxion Daily Regional Banks Bull 3x Shares (NYSEARCA:DPST – Get Free Report)’s stock price gapped up before the market opened...